|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/29 | |||
| A61P 1/16 | |||
| A61P 31/20 | |||
| A61K 35/16 |
| (11) | Number of the document | 3148574 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15799654.7 |
| Date of filing the European patent application | 2015-05-28 | |
| (97) | Date of publication of the European application | 2017-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/032807 |
| Date | 2015-05-28 |
| (87) | Number | WO 2015/184050 |
| Date | 2015-12-03 |
| (30) | Number | Date | Country code |
| 201462003664 P | 2014-05-28 | US |
| (72) |
HOANG, Kieu, US
|
| (73) |
Rare Antibody Antigen Supply, Inc.,
30423 Canwood Street Suite 120, Agoura Hills, CA 91301,
US
|
| (54) | PURIFIED COMPOSITIONS OF IVIG AND KH PROTEINS FOR MODULATING LYMPHOCYTES AND TREATING HEPATITIS B VIRUS |
| PURIFIED COMPOSITIONS OF IVIG AND KH PROTEINS FOR MODULATING LYMPHOCYTES AND TREATING HEPATITIS B VIRUS |